Aviation Medication Transparency Act of 2025
Summary
The Aviation Medication Transparency Act of 2025 aims to increase transparency regarding medications approved for airmen and air traffic control specialists. It mandates the FAA Administrator to publish and maintain a publicly accessible list of approved medications. This list will be developed in consultation with relevant stakeholders and updated annually.
Expected Effects
The Act will likely lead to better-informed aviation personnel and medical providers. It will provide clarity on medication use and FAA medical certification requirements. This could reduce confusion and improve the efficiency of the medical certification process.
Potential Benefits
- Increased transparency for airmen and air traffic controllers regarding approved medications.
- Improved communication between medical providers and the FAA.
- Enhanced safety through better-informed medical decision-making.
- Streamlined medical certification process.
- User-friendly access to critical medication information.
Potential Disadvantages
- Potential administrative burden on the FAA to create and maintain the list.
- Possible delays in updating the list with new medications.
- Risk of misinterpretation of the list by individuals without medical expertise.
- Costs associated with developing and maintaining the website.
- The list may not be exhaustive and could require frequent updates.
Constitutional Alignment
The Act aligns with the general welfare clause of the US Constitution, as it aims to improve public safety and the well-being of aviation personnel. Specifically, it promotes informed decision-making related to health, which falls under the umbrella of promoting the general welfare. The Act does not appear to infringe upon any specific constitutional rights or limitations.
Impact Assessment: Things You Care About ⓘ
This action has been evaluated across 19 key areas that matter to you. Scores range from 1 (highly disadvantageous) to 5 (highly beneficial).